Bioequivalence Study of Two Orally Disintegrating Risperidone Formulations, Risperdal OD® Tablet 1mg and Risperdal Quicklet® Tablet 1mg in Healthy Korean Volunteers
Journal of Korean Society for Clinical Pharmacology and Therapeutics
doi 10.12793/jkscpt.2011.19.1.31
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2011
Authors
Publisher
Korean Society for Clinical Pharmacology and Therapeutics (KAMJE)